Citation: | LIU Qiao, LIU Jue. A review on advances in global malaria epidemiology[J]. Chinese Journal of Public Health, 2023, 39(4): 509-513. doi: 10.11847/zgggws1139898 |
[1] |
World Health Organization. Malaria[EB/OL]. (2022 – 07 – 26). https://www.who.int/news-room/fact-sheets/detail/malaria.
|
[2] |
World Health Organization. Medicines for Malaria Venture, Back R, Severe malaria[J]. Tropical Medicine and International Health, 2014, 19(S1): 7 – 131.
|
[3] |
World Health Organization. Global technical strategy for malaria 2016 – 2030, 2021 update[EB/OL]. (2021 – 07 – 19). https://www.who.int/publications/i/item/9789240031357.
|
[4] |
朱国鼎, 高琪, 曹俊. 取不易守更难: 我国巩固消除疟疾成果面临的挑战[J]. 中国血吸虫病防治杂志, 2022, 34(2): 109 – 111, 114.
|
[5] |
World Health Organization. From 30 million cases to zero: China is certified malaria-free by WHO[EB/OL]. (2021 – 06 – 30). https://www.who.int/news/item/30-06-2021-from-30-million-cases-to-zero-china-is-certified-malaria-free-by-who.
|
[6] |
汤林华. 我国疟疾防治研究成就[J]. 中国寄生虫学与寄生虫病杂志, 1999, 17(5): 257 – 259.
|
[7] |
卫生部, 发展改革委, 教育部, 等. 关于印发《中国消除疟疾行动计划(2010 — 2020年)》的通知[A]. 2010 – 05 – 26.
|
[8] |
杨维中, 贾萌萌. 中国消除传染病的历史进程与展望[J]. 中华流行病学杂志, 2021, 42(11): 1907 – 1911. doi: 10.3760/cma.j.cn112338-20211016-00801
|
[9] |
张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征分析及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 133 – 138. doi: 10.12140/j.issn.1000-7423.2020.02.001
|
[10] |
张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201 – 209.
|
[11] |
张丽, 丰俊, 张少森, 等. 2018年全国疟疾疫情特征及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3): 241 – 247.
|
[12] |
张丽, 丰俊, 涂宏, 等. 2020年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 195 – 199.
|
[13] |
张丽, 易博禹, 夏志贵, 等. 2021年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 135 – 139.
|
[14] |
World Health Organization. World malaria report 2021[EB/OL]. (2021 – 12 – 06). https://www.who.int/publications/i/item/9789240040496.
|
[15] |
Malaria in 2022: a year of opportunity[J]. The Lancet, 2022, 399(10335): 1573.
|
[16] |
Wangmo LD, Belo OMF, Penjor K, et al. Sustaining progress towards malaria elimination by 2025: lessons from Bhutan and Timor-Leste[J]. The Lancet Regional Health – Western Pacific, 2022, 22: 100429.2.
|
[17] |
Kotepui M, Kotepui KU, De Jesus Milanez G, et al. Plasmodium spp. mixed infection leading to severe malaria: a systematic review and meta-analysis[J]. Scientific Reports, 2020, 10(1): 11068. doi: 10.1038/s41598-020-68082-3
|
[18] |
Kojom Foko LP, Arya A, Sharma A, et al. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India[J]. Journal of Infection, 2021, 82(6): 231 – 246. doi: 10.1016/j.jinf.2021.03.028
|
[19] |
Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria?[J]. Parasitology Today, 1991, 7(10): 277 – 281. doi: 10.1016/0169-4758(91)90096-7
|
[20] |
Paton RS, Kamau A, Akech S, et al. Malaria infection and severe disease risks in Africa[J]. Science, 2021, 373(6557): 926 – 931. doi: 10.1126/science.abj0089
|
[21] |
Villarino NF, Lecleir GR, Denny JE, et al. Composition of the gut microbiota modulates the severity of malaria[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(8): 2235 – 2240. doi: 10.1073/pnas.1504887113
|
[22] |
Greenhalgh S, Chandwani V. Advocating an attack against severe malaria: a cost-effectiveness analysis[J]. BMC Public Health, 2020, 20(1): 17. doi: 10.1186/s12889-019-8141-y
|
[23] |
de Laval F, Maugey N, Bonet d’Oléon A, et al. Increased risk of severe malaria in travellers during the COVID-19 pandemic[J]. Journal of Travel Medicine, 2021, 28(6): taab106. doi: 10.1093/jtm/taab106
|
[24] |
Fried M, Duffy PE. Malaria during pregnancy[J]. Cold Spring Harbor Perspectives in Medicine, 2017, 7(6): a025551. doi: 10.1101/cshperspect.a025551
|
[25] |
Walker PG, ter Kuile FO, Garske T, et al. Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study[J]. The Lancet Global Health, 2014, 2(8): e460 – e467. doi: 10.1016/S2214-109X(14)70256-6
|
[26] |
Rahman MM, Abe SK, Rahman MS, et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis[J]. The American Journal of Clinical Nutrition, 2016, 103(2): 495 – 504. doi: 10.3945/ajcn.115.107896
|
[27] |
Tort J, Rozenberg P, Traoré M, et al. Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey[J]. BMC Pregnancy Childbirth, 2015, 15: 235. doi: 10.1186/s12884-015-0669-y
|
[28] |
Duffy PE, Fried M. Pregnancy malaria: cryptic disease, apparent solution[J]. Memórias do Instituto Oswaldo Cruz, 2011, 106(S1): 64 – 69.
|
[29] |
Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women[J]. Cochrane Database of Systematic Reviews, 2006(4): CD000169.
|
[30] |
Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015[J]. Nature, 2015, 526(7572): 207 – 211. doi: 10.1038/nature15535
|
[31] |
Mbacham WF, Ayong L, Guewo-Fokeng M, et al. Current situation of malaria in Africa[M]//Ariey F, Gay F, Ménard R. Malaria Control and Elimination. New York: Humana, 2019: 29 – 44.
|
[32] |
Hemingway J. The role of vector control in stopping the transmission of malaria: threats and opportunities[J]. Philosophical Transactions of the Royal Society B:Biological Sciences, 2014, 369(1645): 20130431. doi: 10.1098/rstb.2013.0431
|
[33] |
Ngufor C, N’Guessan R, Fagbohoun J, et al. Efficacy of the Olyset Duo net against insecticide-resistant mosquito vectors of malaria[J]. Science Translational Medicine, 2016, 8(356): 356ra121.
|
[34] |
Mosha JF, Kulkarni MA, Lukole E, et al. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial[J]. The Lancet, 2022, 399(10331): 1227 – 1241. doi: 10.1016/S0140-6736(21)02499-5
|
[35] |
Meremikwu MM, Donegan S, Sinclair D, et al. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission[J]. Cochrane Database of Systematic Reviews, 2012, 2012(2): CD003756.
|
[36] |
Cairns M, Ceesay SJ, Sagara I, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: case-control studies in 5 countries[J]. PLoS Medicine, 2021, 18(9): e1003727. doi: 10.1371/journal.pmed.1003727
|
[37] |
Gilmartin C, Nonvignon J, Cairns M, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis[J]. The Lancet Global Health, 2021, 9(2): e199 – e208. doi: 10.1016/S2214-109X(20)30475-7
|
[38] |
Desai M, Hill J, Fernandes S, et al. Prevention of malaria in pregnancy[J]. The Lancet Infectious Diseases, 2018, 18(4): e119 – e132. doi: 10.1016/S1473-3099(18)30064-1
|
[39] |
O’Leary K. A malaria vaccine at last[J]. Nature Medicine, 2021, 27(12): 2057.
|
[40] |
World Health Organization. High burden to high impact: a targeted malaria response[EB/OL]. (2018 – 11 – 19). https://www.who.int/publications/i/item/WHO-CDS-GMP-2018.25.
|
[41] |
Wu L, Van Den Hoogen LL, Slater H, et al. Comparison of diagno-stics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies[J]. Nature, 2015, 528(7580): S86 – S93. doi: 10.1038/nature16039
|
[42] |
Mappin B, Cameron E, Dalrymple U, et al. Standardizing Plas-modium falciparum infection prevalence measured via microscopy versus rapid diagnostic test[J]. Malaria Journal, 2015, 14(1): 460. doi: 10.1186/s12936-015-0984-9
|
[43] |
Yin JH, Yan H, Li M. Prompt and precise identification of various sources of infection in response to the prevention of malaria re-establishment in China[J]. Infectious Diseases of Poverty, 2022, 11(1): 45. doi: 10.1186/s40249-022-00968-y
|